Pharma News

academics

 

Clinical research courses

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Drug Safety Symposium 2024
    4 July 2024

    Drug Safety Symposium 2024 – India Chapter Revolutionizing Pharmacovigilance Practices in India

    The Drug Safety Symposium 2024 – India Chapter, held over two action-packed days, brought together industry leaders, experts, and professionals to explore innovative strategies and collaborative efforts in pharmacovigilance. With insightful, interactive, and robust sessions, the event highlighted the future of drug safety in India, emphasizing the importance of regulatory compliance, data integrity, and cutting-edge technologies like AI in enhancing pharmacovigilance systems.

  • 1 July 2024
    Breakthrough research makes cancer-fighting viral agent more effective
    Researchers from Aarhus University have made a significant breakthrough by discovering that the drug 4-OI can enhance the effectiveness of a cancer-fighting viral agent. This may lead to treatment of cancers that are otherwise resistant to therapies.
  • 1 July 2024
    Study reveals why AI models that analyze medical images can be biased
    Artificial intelligence models often play a role in medical diagnoses, especially when it comes to analyzing images such as X-rays. However, studies have found that these models don’t always perform well across all demographic groups, usually faring worse on women and people of color.
  • 1 July 2024
    Cosmohome Tech Expo 2024

    Cosmohome Tech Expo was held in Delhi at Pragati Maidan from 26th to27st June 2024. It was its 10th edition, comprising of more than 350 Exhibitors who displayed  latest Ingredients, Formulations, Fragrances, Packaging, Instruments, Machinery, Labelling and Contract Manufacturing.

  • 27 June 2024
    New Approach Accurately Identifies Medications Most Toxic to the Liver
    The current method for assessing medication-related liver injury is not providing an accurate picture of some medications toxicity or lack thereof to the liver, according to a new study led by researchers from the Perelman School of Medicine at the University of Pennsylvania. Classification of a medication’s potential to damage the liver, termed hepatotoxicity, has been historically determined by counting individual reported cases of acute liver injury
  • 27 June 2024
    New study demonstrates the efficacy of a promising celiac disease drug at the molecular level

    A recent study led by researchers at Tampere University investigated whether a transglutaminase 2 inhibitor has potential as a drug to treat celiac disease. Previous tissue studies have shown that the ZED1227 transglutaminase 2 inhibitor prevents gluten-induced intestinal damage. The results of the new study, based on an analysis of the molecular activity of more than 10,000 genes, provide very strong evidence that the first successful drug to treat celiac disease may be at hand.

  • 26 June 2024
    Novo Nordisk announces 4.1 billion USD investment to expand US manufacturing capacity
    Novo Nordisk today announced plans to invest 4.1 billion US dollars (approx 27 billion Danish kroner) to build a second fill and finishing manufacturing facility in Clayton, North Carolina, and grow its ability to produce current and future injectable treatments for people with obesity and other serious chronic diseases.
  • 26 June 2024
    USDA approves Merck Animal Health’s NOBIVAC NXT Canine Flu H3N2
    NOBIVAC NXT is a revolutionary, first-of-its-kind vaccine technology for companion animals that leverages RNA-particle technology, allowing for a precise immune response to protect against a wide range of viral and bacterial pathogens.
  • 25 June 2024
    EMA approves Biocon Biologics’ New mAbs Facility in India and Renews GMP Certifications for India and Malaysia Sites
    Biocon Biologics Ltd , a global, fully integrated biosimilars company and a subsidiary of Biocon Ltd, has received approval from the European Medicines Agency to manufacture biosimilar Bevacizumab at its new, world-class, multi-product monoclonal antibodies mAbs drug substance facility at Bengaluru.
  • 25 June 2024
    US lawmakers probe USFDAs inspection in India and China
    US lawmakers probe USFDAs inspection in India and China where they found many variations in inspection outcomes. In a new letter to Food and Drug Administration (FDA) Commissioner Robert Califf, House Energy and Commerce Committee Chair Cathy McMorris Rodgers, Subcommittee on Health Chair Brett Guthrie, and Subcommittee on Oversight and Investigations Chair Morgan Griffith are pressing for more information regarding the agency’s foreign drug inspection program.
Subscribe to Pharma News

Subscribe with us




 


 

 

Do Not Forget to Verify

(Click on Subscription link in your inbox)

--------

whatsapp

 

Also Join:  youtube  telegram

Clini India

 

PC-ISIT

Jobs by Category

Production Jobs

R&D Jobs

F&D Jobs

Sales & Marketing

QA Jobs

QC Jobs

Faculty Jobs

CRO Jobs

DRA Jobs

IPR Jobs

IT Jobs

Packaging Alerts

Hospital Pharmacist